← 返回前沿论文

TIL(肿瘤浸润淋巴细胞)最佳比例预测肝内胆管癌临床结局的价值:单中心回顾性分析

英文原题:Utility of optimal proportion of tumor-infiltrating lymphocytes as a prognostic prediction of clinical outcome in intrahepatic cholangiocarcinoma: a single institution retrospective analysis.

查看英文原题

Utility of optimal proportion of tumor-infiltrating lymphocytes as a prognostic prediction of clinical outcome in intrahepatic cholangiocarcinoma: a single institution retrospective analysis.

PubMed 2025/11/24(内容时间) Diagn Pathol Q1 · IF 3.5(JCR 2025)

研究概要

在本研究中,我们确定了用于早期iCCA患者预后预测的最佳间质TILs比例。需要进一步研究以验证TILs作为预后生物标志物的作用,并探索其在指导早期疾病患者监测和风险分层中的潜在用途。

研究思路结论见上方概要

肝内胆管癌(iCCA)在泰国东北部高发,由于诊断晚和转移,其治疗面临挑战。预后因素至关重要。TIL(肿瘤浸润淋巴细胞)(TILs)有望作为预后指标和用于免疫治疗,但其在iCCA预后中的最佳比例尚未确定。我们拟评估TILs预测iCCA结局的最佳比例。

我们分析了190例iCCA病例中的TIL水平,涵盖四种不同TIL截断值的模型。随后检查了其与临床病理特征的相关性,并进行了单因素和多因素生存分析。亚组分析区分了早期和晚期疾病,以评估TILs的预测潜力。

结果显示,至少20%的TIL与较小的肿瘤尺寸及导管内(ID)型和ID混合型生长模式显著相关。多变量分析显示,20%-40%的TIL是预测患者良好生存的独立因素。此外,20%的截断值是预测早期疾病患者生存结果的独立因素。

展开英文摘要原文

BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA), prevalent in Northeastern Thailand, presents challenges due to late diagnosis and metastasis. Prognostic factors are crucial. Tumor-infiltrating lymphocytes (TILs) hold promise as prognostic indicators and for immunotherapy, but their optimal proportion in iCCA prognosis is yet to be determined. We propose to evaluate the optimal proportion of TILs for predicting the outcomes of iCCA. METHODS: We analyzed TIL levels in 190 iCCA cases across four models with varying TIL cut-offs. Correlations with clinicopathological features were examined, followed by univariate and multivariate survival analyses. Subgroup analysis differentiated early and late-stage disease to assess TILs predictive potential. RESULTS: Results showed that at least 20% of TILs were significantly associated with smaller tumor size and growth patterns of intraductal (ID) and ID mixed types. Multivariate analysis revealed that 20%-40% of TILs were an independent factor for predicting good survival of patients. In addition, the 20% cut-off value was an independent factor for predicting the survival outcome of patients with early-stage disease. CONCLUSION: In this study, we identified the optimal proportion of stromal TILs for prognostic prediction in early-stage iCCA patients. Further research is warranted to validate the role of TILs as a prognostic biomarker and to explore their potential utility in guiding patient monitoring and risk stratification in early-stage disease.

论文信息

作者
Kunprom W、Poonsiri N、Intarawichian P、Sa-Ngiamwibool P、Sangkhamanon S、Thanee M、Loilome W、Titapun A
第一作者单位
Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.Thailand
通讯作者单位
Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. chaiap@kku.ac.th.Thailand
期刊
Diagnostic pathology2025 Nov 24
原文标识
PubMed 41286924 · DOI 10.1186/s13000-025-01733-z